ELVN

• 2026-06-12 share offering or dilution eventfreshOpen filing ↗
  “…stock issuable upon exercise of each Pre-Funded Warrant are subject to appropriate adjustments in the event of certain stock…”
  +1 more passage from the same document

  • “…is exercisable, in the holder’s discretion, by (i) payment in full in immediately available funds for the number of shares of…”
• 2026-06-12 share offering or dilution eventfreshOpen filing ↗
  “…August 13, 2025) 8,933,334 Shares of Common Stock Pre-Funded Warrants to Purchase 1,733,333 Shares of Common Stock We are offering…”
  +1 more passage from the same document

  • “…stock to investors that so choose, pre-funded warrants to purchase up to 1,733,333 shares of our common stock in this offering.…”
• 2026-06-12 capital return (buybacks/dividends)freshOpen filing ↗
  “…where the securities of such series may be surrendered for registration of transfer or exchange, and where notices and demands to us…”
  +1 more passage from the same document

  • “…to an agreement or equity awards granted under a stock incentive plan or other equity award plan, each such agreement or plan…”
• 2026-06-12 merger or acquisition eventfreshOpen filing ↗
  “…FDA, including at a planned End-of-Phase 2 meeting anticipated in the third quarter of 2026. Corporate Information Enliven Inc.…”
  +1 more passage from the same document

  • “…solve complex medicinal chemistry problems in a target- and indication-agnostic approach. Corporate Information Enliven Inc.…”
• 2026-06-12 reverse splitfreshOpen filing ↗
  “…a Delaware corporation and our wholly owned subsidiary (“Merger Sub”), pursuant to which, among other matters, Merger Sub merged…”
• 2026-06-11 share offering or dilution eventfreshOpen filing ↗
  “…dated August 13, 2025) $250,000,000 Shares of Common Stock Pre-Funded Warrants to Purchase Shares of Common Stock We are…”
  +1 more passage from the same document

  • “…of common stock to investors that so choose, pre-funded warrants to purchase up to shares of our common stock in this offering.…”
• 2026-06-11 capital return (buybacks/dividends)freshOpen filing ↗
  “…where the securities of such series may be surrendered for registration of transfer or exchange, and where notices and demands to us…”
  +1 more passage from the same document

  • “…to an agreement or equity awards granted under a stock incentive plan or other equity award plan, each such agreement or plan…”
• 2026-06-11 merger or acquisition eventfreshOpen filing ↗
  “…FDA, including at a planned End-of-Phase 2 meeting anticipated in the third quarter of 2026. Corporate Information Enliven Inc.…”
  +1 more passage from the same document

  • “…solve complex medicinal chemistry problems in a target- and indication-agnostic approach. Corporate Information Enliven Inc.…”

1 older entry not shown

Recorded SEC filings in plain language — not advice or a prediction.